Integrated Wealth Concepts LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1737109 WALTHAM, MA

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,778,095

+$92,059 QoQ

Shares Held

5,374

+26.7% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Integrated Wealth Concepts LLC holds $33,789,797 across 56 Biotechnology names. ALNY ranks #8 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	85,447	$4,826,901
2	INVA	Innoviva, Inc.	165,214	$3,849,486
3	EXEL	Exelixis, Inc.	78,901	$3,384,063
4	REGN	Regeneron Pharmaceuticals, Inc.	4,201	$3,245,860
5	INCY	Incyte Corp	23,056	$2,170,030
6	VRTX	Vertex Pharmaceuticals Inc / Ma	4,668	$2,084,448
7	DNLI	Denali Therapeutics Inc.	99,554	$1,911,436
8	ALNY	Alnylam Pharmaceuticals, Inc. This page	5,374	$1,778,095

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,778,095	5,374	+26.7%	Shares	Other	2026-05-15
2025-12-31	$1,686,036	4,240	-8.5%	Shares	Other	2026-02-13
2025-09-30	$2,114,016	4,636	+34.6%	Shares	Other	2025-11-14
2025-06-30	$1,123,380	3,445	+25.8%	Shares	Other	2025-08-14
2025-03-31	$739,584	2,739	+9.0%	Shares	Other	2025-05-15
2024-12-31	$591,098	2,512	+7.5%	Shares	Other	2025-02-14
2024-09-30	$642,470	2,336	+1.0%	Shares	Other	2024-11-14
2024-06-30	$562,302	2,314	-0.3%	Shares	Other	2024-08-14
2024-03-31	$346,724	2,320	+1.4%	Shares	Other	2024-05-15
2023-12-31	$438,137	2,289	+0.7%	Shares	Other	2024-02-13
2023-09-30	$402,725	2,274	+0.1%	Shares	Other	2023-11-15
2023-06-30	$431,353	2,271	-5.6%	Shares	Other	2023-08-15
2023-03-31	$481,969	2,406	—	Shares	Other	2023-05-03
No filing history on record for this holder in this stock.